Key facts
- Employers are implementing stricter requirements for GLP-1 weight-loss drug approvals.
- New requirements include mandatory weigh-ins.
- New requirements include app tracking for health.
- New requirements include health coaching.
- Some companies are discontinuing coverage for these drugs.
- Some companies are considering removing coverage for these drugs.
- The trend is driven by the rising cost and demand for GLP-1 drugs.
- Drugs like Ozempic and Wegovy are examples of GLP-1 medications.
Employers are responding to the growing demand and cost of GLP-1 weight-loss drugs by implementing stricter approval requirements. These new measures often mandate that employees meet specific criteria before coverage is granted. Common requirements include regular weigh-ins to demonstrate ongoing weight loss, the use of health-tracking applications to monitor progress, and participation in health coaching programs designed to support lifestyle changes. These steps aim to ensure the medications are used appropriately and to manage the significant financial burden they place on employer-sponsored health plans. The rising popularity and associated costs of drugs such as Ozempic and Wegovy have prompted this shift in coverage policies. In some cases, employers are not just tightening rules but are also considering or actively removing these medications from their formularies entirely. This move reflects a broader trend of employers scrutinizing drug costs and seeking ways to control healthcare spending, particularly for high-cost specialty medications.